Drugs / Teribone Inj.
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06644040 Comparator | Oct → Dec 2024 | osteoporosis | QuadMedicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Teribone Inj. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06644040 ↗ |
| Known as | Teribone Injection | “This study will compare TeriQ Patch with two active comparators, Teribone Injection and Forteo Injection, to evaluate the safety, tolerability, and pharmacokinetics of TeriQ...” NCT06644040 ↗ |